If hospice leaders were hoping for meaningful financial relief in 2027, the proposed rule only offers part of the answer.
The Centers for Medicare and Medicaid Services (CMS) is proposing a 2.4% payment increase, which amounts to an estimated $785 million in additional Medicare hospice payments. But beneath that headline number is a more complex reality. Costs, especially clinical labor, continue to rise faster than reimbursement. At the same time, regulatory expectations are expanding in ways that will directly impact how organizations operate day to day.
The takeaway is clear: This is not a rule that reshapes margins. It is a rule that raises expectations.
A Payment Update That Doesn’t Change the Fundamentals
The proposed 2.4% payment rate increase is driven by a 3.2% market basket update, offset by a 0.8% productivity adjustment. While that results in a net increase, it doesn’t materially shift the financial outlook for most hospice providers.
Labor is still a dominant cost driver, and those expenses are increasing at a pace that outstrips reimbursement. Meanwhile, changes to the wage index largely redistribute dollars geographically rather than improving margins across the board.
Even at the level of care, where rates increase in line with the overall update, the actual impact will vary widely. What organizations receive will continue to depend heavily on where they operate and how they staff their teams.
In other words, the rate increase is real, but it is modest. Financial performance will still come down to execution.
Geography Continues to Shape Financial Outcomes
Although the national update is modest, the actual impact varies significantly by region. These differences are primarily driven by wage index and CBSA updates. As a result, some regions benefit from the update while others see much smaller changes in their reimbursement. Because of that, the benchmarking, forecasting and performance expectations all need to be grounded in local economics and not just national averages.
For hospice leaders, that raises the stakes on localized decision-making across staffing models and growth strategies.
The Hospice Cap Remains a Pressure Point
The proposed payment update would also increase the hospice aggregate cap amount,bringing it to just over $36,000 per beneficiary. While this keeps the cap aligned with the broader rate-setting methodology, it does little to relieve operational pressure.
For organizations with longer average lengths of stay, the cap continues to be a limiting factor, especially in a high-cost environment. It may keep pace with rate updates, but it does not keep pace with inflation.
That gap reinforces a familiar reality. Managing length of stay and cost structure remains critical to financial sustainability.
The Election Addendum Becomes a Front-End Priority
Among the more significant operational changes in the proposed rule centers on the hospice election statement addendum.
Right now, providers are only required to provide the addendum when requested. Under the new proposal, it would be required for all beneficiaries or their representatives at the time of hospice election, beginning in October 2026.
This change reflects a broader push by CMS to improve transparency around what is and is not covered under the hospice benefit. The addendum must clearly outline non-covered items, services and drugs, along with a plain-language clinical explanation supporting those determinations. It must also be updated within three days of any change in the plan of care.
While CMS believes this will reduce confusion and administrative burden across the system, it shifts significant responsibility to hospice providers.
Admission workflows will need to be enhanced. Hospice physicians and team members will need training to consistently determine and document related versus unrelated services and covered vs uncovered items, services and drugs. Coordination with non-hospice providers will need to become more structured and timely.
For many organizations, this elevates the addendum from a compliance task to a core operational process.
SSVI Introduces a New Level of Oversight
The introduction of the Service Spending Variation Index (SSVI) signals a shift in how CMS will monitor performance. It would serve as a new composite scoring system assessing hospice utilization, service intensity, spending and discharge patterns.
It measures nine claims-based metrics that include live discharges, long patient stays, skilled nursing visit frequency and weekend coverage with heavy emphasis on non-hospice spending.
Based on a hospice’s performance, they would receive a score ranging from 0 to 16, with a higher score indicating greater potential for compliance risks and oversight focus. CMS will calculate the scores annually and make them available to the public, using them to guide education, audits and enforcement actions.
Non-Hospice Spending Draws Increased Scrutiny
The emphasis on non-hospice spending helps explain several of the rule’s changes.
Medicare spending outside the hospice benefit during hospice elections has increased by 160% between 2020 and 2024, surpassing $2 billion.
CMS wants to tighten expectations around how eligibility, care planning and billing align.
The goal is to reinforce the need for greater visibility into services delivered outside the hospice benefit and stronger coordination with external partners. Misalignment in this area is becoming a clear compliance risk.
Regulatory Updates Add Flexibility, with Conditions
Along with new requirements, the proposed rule includes some clarifications designed to improve operational flexibility.
CMS is proposing to clarify that physician designees and physician members of the interdisciplinary group can issue discharge orders.
Telehealth flexibility for recertification would also be extended through 2027, though there would be specific safeguards tied to oversight status and provider eligibility.
New reporting requirements would require organizations to document telehealth encounters on claims, linking them directly to recertification activity.
These proposed changes offer opportunities to streamline operations, but they also require updates to policies, systems and staff education to maintain compliance.
Quality Reporting Becomes a Business Risk
Quality reporting is taking on a new level of importance.
The transition to the HOPE assessment tool continues, with an expectation that hospices meet a 90% timeliness threshold for submitting required data. Falling short would result in a 4% payment penalty.
Organizations that meet requirements receive the full payment update. Those that don’t can experience a net negative adjustment, creating a meaningful swing in revenue.
CMS is also proposing a Care Compare icon that would indicate hospices that lack sufficient quality data. While intended to signal incomplete reporting rather than poor performance, the distinction may not be clear to patients and referral sources.
This introduces a new dynamic. Quality reporting is no longer just a regulatory requirement. It is a factor in both financial performance and market perception.
CMS Signals Where Hospice is Heading Next
The rule also includes several requests for information that point to CMS’ longer-term priorities.
These include:
- Enhancing community palliative care — CMS is trying to understand how access and coordination could improve in palliative and hospice settings
- Hospice-specific wage index — CMS is exploring whether hospice-specific data could better reflect the labor cost over time in hospice
- Medical Aid in Dying (MAID) policies — CMS wants input from agencies that are located in states where MAID is legal under the state law. Their interest is in the operational challenges they face to ensure that no Medicare funds can be used to facilitate MAID.
While no immediate policy changes are tied to these topics, they offer providers an opportunity to shape future direction and prepare for what may come next.
What This Means for Hospice Leaders
Under the 2027 proposed rule, success would depend less on rate changes and more on how effectively organizations manage compliance, documentation and performance.
This includes enhancing admission workflows, strengthening team training, improving visibility into utilization patterns and aligning care planning with billing practices.
More importantly, it requires a shift in mindset. Organizations that take a proactive, data-driven approach will be better positioned to adapt to any changes made to the proposed rule.
Are You Prepared for What Lies Ahead?
Whether you’re strengthening compliance programs or improving financial performance, McBee helps you move forward with confidence.


About the Author
Dee Geray, Senior Manager, Clinical Consulting Services,
Dee Geray, RN, is a Senior Clinical Consulting Manager at McBee with more than 20 years of experience working in the hospice industry. She has extensive expertise in hospice clinical compliance, case management, and leadership, and works with hospice providers nationwide to perform Medicare compliance reviews and establish internal audit plans.
About the Author
Dhaval Patel, Director, Advisory Consulting
Dhaval Patel, is a Director in Advisory Consulting at McBee with more than 10 years of experience across post‑acute, home health, hospice, and health system settings. He brings deep expertise in healthcare financial performance, revenue cycle optimization, and regulatory compliance, and serves as a trusted advisor to provider organizations, health systems, and state agencies nationwide. Dhaval has led complex operational and financial transformations, helping organizations improve access, enhance quality outcomes, and drive sustainable growth through data‑driven strategy, workflow redesign, and alignment of clinical and financial operations.
Never miss an update. Subscribe to our blog and get the top industry insights delivered right to your inbox.

